Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
23.70
-0.60 (-2.47%)
At close: Sep 3, 2026, 4:00 PM EDT
23.69
-0.01 (-0.04%)
After-hours: Sep 3, 2026, 7:30 PM EDT

Collegium Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
129.47231.2570.57238.95173.69186.43
Short-Term Investments
-155.4392.271.6--
Cash & Short-Term Investments
129.47386.68162.76310.55173.69186.43
Cash Growth
-41.72%137.57%-47.59%78.80%-6.83%7.07%
Receivables
285.1211.33228.54179.53183.12105.84
Inventory
113.2740.9135.5632.3346.517.39
Prepaid Expenses
60.3326.9321.9411.0511.495.85
Restricted Cash
19.8519.8525---
Other Current Assets
-5.728.454.155.20.03
Total Current Assets
608.01691.41482.26537.6419.99315.54
Property, Plant & Equipment
14.4416.220.1522.0126.3827.14
Goodwill
190.18145.93162.33133.86133.7-
Other Intangible Assets
1,186669.51891.4421.71567.47268.72
Long-Term Deferred Tax Assets
120.77112.5498.0326.2623.9578.04
Other Long-Term Assets
16.321.259.421.872.652.63
Total Assets
2,1361,6571,6641,1431,174692.08

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.2410.663.938.693.494.19
Accrued Expenses
282.18227.32251.55185.26193.07167.75
Current Portion of Long-Term Debt
552964.58183.33162.548.35
Current Portion of Leases
1.561.411.270.991.110.81
Current Income Taxes Payable
1.143.38.532.14-0.62
Current Unearned Revenue
0.670.67----
Other Current Liabilities
240.08167.67179.6477.5173.5557.84
Total Current Liabilities
589.86440.03509.51457.92433.73279.57
Long-Term Debt
1,158901.89908.52483.84538.45201.63
Long-Term Leases
3.414.135.546.127.117.95
Long-Term Unearned Revenue
8.789.1110---
Other Long-Term Liabilities
22.96-1.18---
Total Liabilities
1,8241,3551,435947.88979.29489.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.040.040.040.040.040.04
Additional Paid-In Capital
636.06624.95590.25565.95538.07502.1
Retained Earnings
-101.68-101.13-164-233.19-281.34-256.34
Treasury Stock
-222.51-222.51-197.51-137.38-61.92-42.86
Comprehensive Income & Other
-0.320.060.01--
Shareholders' Equity
311.91301.68228.84195.43194.84202.93
Total Liabilities & Equity
2,1361,6571,6641,1431,174692.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,218936.43979.91674.28709.18258.75
Net Cash (Debt)
-1,088-549.75-817.15-363.74-535.49-72.32
Net Cash Growth
------
Net Cash Per Share
-30.07-13.85-20.21-8.70-15.83-1.76
Filing Date Shares Outstanding
32.5631.7531.4931.9634.0733.38
Total Common Shares Outstanding
32.531.7131.4431.8733.8533.66
Working Capital
18.15251.38-27.2579.69-13.7435.98
Book Value Per Share
9.609.517.286.135.766.03
Tangible Book Value
-1,064-513.76-824.89-360.13-506.32-65.8
Tangible Book Value Per Share
-32.75-16.20-26.24-11.30-14.96-1.95
Machinery
-25.5825.8324.624.9718.46
Construction In Progress
-1.750.8--5.18
Leasehold Improvements
-1.231.231.060.870.54
SEC Filings: 10-K · 10-Q